Neo Proteomics offer a wide range of mass spectrometry, biophysics, and structural biology services including: peptide mapping, epitope mapping, glycosylation analysis, PTM analysis, quantitative proteomic and phosphoproteomics, structural mass spectrometry, crystallization trials, synchrotron data collection and structural solution.

Epitope Mapping and Protein-Drug binding: Neo specializes in advanced epitope mapping and protein structure assessment using covalent-labeling mass spectrometry (CL-MS). These approaches can establish IP protection for novel biotechnology products as well as define structure parameters important for regulatory filings in the case of both innovator and biosimilars products. CL-MS precisely defines drug and epitope binding sites and provides detailed structural characterization of protein-drug complexes. Specifically CL-MS (often called protein footprinting) provides a high resolution and sensitive readout of the amino acid side chain environment (e.g. solvent accessibility) for virtually all amino acids in a protein of interest.

Crystallography: Neo has advanced capabilities for macromolecular crystallography services at advanced synchrotron sources. Services from crystallization trials to data collection to structural solution are available including rapid turnaround.